Skip to content
Search

Latest Stories

Human case of bird flu confirmed in West Midlands

Human case of bird flu
Human case of avian flu confirmed in West Midlands

Despite this confirmed case, the risk of bird flu to the general public remains very low- says Professor Susan Hopkins

The UK Health Security Agency (UKHSA) has confirmed a case of avian influenza A(H5N1), commonly known as avian flu or bird flu, in a person from the West Midlands.

The affected person was admitted to a High Consequence Infectious Disease (HCID) unit and is reported to be doing well.


According to UKHSA, the person acquired the infection after prolonged close contact with infected birds on a farm.

Despite this confirmed case, Professor Susan Hopkins, chief medical adviser at UKHSA, reassured the public that the risk of avian flu to the general public remains “very low.”

She acknowledged the potential for spillover infections from birds to humans and emphasised that robust systems are in place to detect cases early and take necessary action.

She also confirmed no evidence of onward transmission from this case but urged people to avoid touching sick or dead birds and to report suspected cases.

The case was detected after an outbreak of avian influenza(H5N1) in a flock of birds was identified, prompting the UKHSA to conduct routine monitoring of individuals who had been in close contact with the infected birds.

The infected birds were found carrying the DI.2 genotype of the virus, which is circulating among UK birds this season.

UKHSA has been tracing all individuals who may have been exposed to the confirmed case and those at highest risk have been offered antiviral treatment to prevent potential infection.

Measures to contain the outbreak

Christine Middlemiss, the UK’s chief veterinary officer, emphasised that while avian influenza is highly contagious among birds, human cases remain very rare.

She said that all infected birds at the site have been humanely culled, and the premises are undergoing cleansing and disinfection under strict biosecurity protocols to contain the spread of the disease.

Middlemiss also highlighted the growing number of bird flu cases in both commercial and backyard flocks across the country, stressing the importance of stringent biosecurity measures when keeping animals.

Andrew Gwynne, minister for public health and prevention, assured the public that the government is closely monitoring the situation.

“The risk of wider or onward transmission is very low, however the UK remains prepared and ready to respond to any current and future health threats,” Gwynne stated.

As part of its preparedness plan, the government has added the H5 vaccine, which offers protection against avian influenza, to its national stockpile.

Bird-to-human transmission of avian influenza is rare, with only a small number of cases previously recorded in the UK.

 

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less